Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Birth Satisfaction in Women After Spontaneous Vaginal Birth, Planned Cesarean, or Cesarean During Labor (BLISS)

11 de noviembre de 2026 actualizado por: Ayşenur Türe, Ankara City Hospital Bilkent

The Effect of Mode of Birth on Maternal Satisfaction Assessed With the Birth Satisfaction Scale-Revised (BSS-R): A Comparison of Spontaneous Vaginal Birth, Planned Cesarean Section, and Intrapartum Cesarean Section

The goal of this observational study is to learn whether women's satisfaction with their birth experience differs by mode of birth. It includes women aged 18 to 45 years who gave birth to a single, live, full-term baby at Ankara Bilkent City Hospital. Three groups are compared: spontaneous vaginal birth, planned cesarean section performed before labor starts, and cesarean section decided during labor (intrapartum cesarean section).

The main question it aims to answer is:

- Do birth satisfaction scores, measured with the Turkish version of the Birth Satisfaction Scale-Revised (BSS-R), differ among these three modes of birth?

Researchers will also look at whether birth satisfaction is related to pain after birth, to how much women felt involved in decisions about how they gave birth, to personal and newborn factors, and to how many hours after birth the questionnaire was completed.

The study does not change the mode of birth or any part of routine care. Between 24 and 48 hours after birth, before going home, participants fill in a short questionnaire once (about 10 to 12 minutes). Information about labor, birth, the baby, and routinely recorded pain scores is taken from hospital records. No extra tests or procedures are done for the study.

Descripción general del estudio

Descripción detallada

Background The World Health Organization identifies a positive childbirth experience as a key outcome of intrapartum care, and patient-reported outcome measures are a priority area in current obstetric research. A negative birth experience has been associated with postpartum depression, fear of childbirth, and requests for cesarean section in a subsequent pregnancy. Given the high cesarean section rates in Türkiye, describing the effect of a cesarean section decided during labor on the birth experience may reveal areas for improvement in labor management and patient communication. The Birth Satisfaction Scale-Revised (BSS-R) is a standardized instrument that allows international comparison, and a validated Turkish version (T-BSS-R) is available.

Design and setting Single-center, non-interventional, observational, analytical cross-sectional study with prospective data collection in the postpartum ward of Ankara Bilkent City Hospital, Ankara, Türkiye. Participants in all three groups are recruited consecutively from the same ward, which minimizes center-related differences in care. Routine care is not changed and no intervention is applied.

Study groups

  1. Spontaneous vaginal birth
  2. Planned (elective) cesarean section, performed before the onset of labor
  3. Intrapartum cesarean section, decided during labor Women with an operative vaginal birth (vacuum or forceps) are not included in the main analysis, because the experience of this mode of birth differs from both spontaneous vaginal birth and cesarean section; their number and scores are reported descriptively.

Data collection

Between 24 and 48 hours after birth and before discharge, participants complete:

  • a sociodemographic and psychosocial form: age, education level, employment status, perceived income, gravidity, parity, whether the pregnancy was planned, antenatal childbirth education, presence of a birth companion, preferred mode of birth during pregnancy, and history of anxiety or depression diagnosed during pregnancy and its treatment (history question only; no psychiatric scale is administered);
  • the Turkish version of the BSS-R (10 items; total score and three subscales: quality of care provision, women's personal attributes, and stress experienced during labour);
  • two 5-point Likert items on perceived involvement in decisions: "I felt I was able to participate in decisions about my mode of birth" and "I was given enough information". These items are analyzed as separate variables and are not included in the BSS-R score.

Forms are self-administered. For participants with reading difficulty, the researcher reads the items aloud verbatim without guidance; the mode of administration (self-report or read aloud) is recorded and used as a variable in the analysis.

The following data are obtained from delivery room records, nursing observation forms, and the hospital information system: cesarean indication, labor onset, induction of labor and method, oxytocin, epidural analgesia, duration of the stages of labor, episiotomy and perineal tears, type of anesthesia, gestational age at birth, birth weight, 1- and 5-minute Apgar scores, neonatal intensive care admission (recorded; exclusion criterion), pain score at the time of the survey on a 0-10 Visual Analog Scale (VAS) as recorded in routine ward pain monitoring, analgesic use in the previous 24 hours, time to initiation of breastfeeding, and feeding method at discharge. All clinical data are generated during routine care, and no additional measurements are made for the study. Time from birth to assessment (hours) is recorded as a continuous variable.

Timing of assessment Because all three groups are assessed in the same postpartum time window, any effect of early assessment is expected to be non-differential across groups. Such an effect would not systematically bias the group comparison; it may compress scores toward the ceiling and reduce the power to detect differences, which is a conservative bias. Time from birth to assessment is therefore included as a covariate, and this limitation will be addressed in the study report.

Statistical analysis Data will be analyzed with SPSS (IBM Corp., USA). Normality will be assessed with the Shapiro-Wilk test. Descriptive statistics will be presented as mean and standard deviation or median and interquartile range, and as number and percentage.

Primary analysis: BSS-R total and subscale scores of the three groups will be compared with one-way analysis of variance and the Tukey post-hoc test, or with the Kruskal-Wallis test and Bonferroni-adjusted Dunn test if parametric assumptions are not met. To assess a ceiling effect, the distribution of total scores and the proportion of participants with the highest possible score will also be reported.

Multivariable analysis: independent predictors of the BSS-R total score will be examined with multiple linear regression. The variables are pre-specified: mode of birth (dummy variables; reference: spontaneous vaginal birth); age, education level, and perceived income (control variables); parity; postpartum VAS score; induction of labor; epidural analgesia; presence of a birth companion; preferred mode of birth during pregnancy; history of anxiety or depression during pregnancy; 5-minute Apgar score and birth weight (newborn outcomes); and time from birth to assessment. Model assumptions (linearity, normality of residuals, homoscedasticity, and multicollinearity with VIF below 5) will be checked. Results will be reported as unstandardized and standardized coefficients with 95% confidence intervals.

Additional analyses: the association between BSS-R and VAS scores will be examined with Pearson or Spearman correlation, and the association between the decision-involvement items and BSS-R total and subscale scores with correlation analysis; these items will be reported separately without being added to the scale score. Internal consistency of the scale will be assessed with Cronbach's alpha. The effect of the mode of administration (self-report or read aloud) on scores will be tested in a sensitivity analysis. A two-sided p value below 0.05 will be considered statistically significant.

Participant protection Written informed consent is obtained from all participants, who are informed that no direct individual medical benefit is expected. The anticipated burdens are the time needed to complete the questionnaire (about 10-12 minutes) and possible mild emotional discomfort when recalling a difficult birth. Participants may leave any question unanswered, take a break, or stop at any time; if distress is expressed, the assessment is stopped immediately and referral to the institutional psychosocial support unit is offered on request. Participants may withdraw at any time without giving a reason and without any effect on their care; on request, their data are excluded from the analysis and destroyed. Permission to use the BSS-R was obtained from the copyright holders.

Tipo de estudio

De observación

Inscripción (Estimado)

180

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 45 años (Adulto)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Femenino

Método de muestreo

Muestra no probabilística

Población de estudio

Women aged 18 to 45 years who gave birth to a singleton live infant at 37 or more weeks of gestation at Ankara Bilkent City Hospital, a large tertiary-care public hospital in Ankara, Türkiye, and who are followed in the hospital's postpartum ward between 24 and 48 hours after birth. Women are recruited consecutively and grouped by mode of birth: spontaneous vaginal birth, planned cesarean section performed before the onset of labor, or cesarean section decided during labor.

Descripción

Inclusion Criteria:

  • Women aged 18 to 45 years
  • Singleton live birth at 37 or more completed weeks of gestation
  • Between 24 and 48 hours after birth at the time of assessment
  • Literate in Turkish
  • Written informed consent

Exclusion Criteria:

  • - Stillbirth or early neonatal death
  • Admission of the newborn to the neonatal intensive care unit
  • Hypertensive disorders of pregnancy (preeclampsia, eclampsia, or HELLP syndrome)
  • Known major fetal anomaly
  • Severe maternal complication (massive hemorrhage or maternal intensive care unit admission)
  • Diagnosed psychiatric disorder under active treatment
  • Communication difficulty that prevents completion of the questionnaire
  • Operative vaginal birth (vacuum or forceps); these women are excluded from the main analysis and reported descriptively only

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Modelos observacionales: COHORT
  • Perspectivas temporales: PROSPECTIVE

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
Spontaneous Vaginal Birth

Women who gave birth by spontaneous vaginal birth, without vacuum or forceps assistance.

Vaginal birth without vacuum or forceps assistance. The mode of birth is determined by routine obstetric care and is not assigned by the investigators; it is the exposure of interest in this observational study.

Otros nombres:
  • Normal vaginal delivery
Planned Cesarean Section

Women who gave birth by a planned (elective) cesarean section performed before the onset of labor.

Cesarean section scheduled and performed before the onset of labor. The mode of birth is determined by routine obstetric care and is not assigned by the investigators.

Intrapartum Cesarean Section

Women who gave birth by a cesarean section decided during labor, after spontaneous or induced onset of labor.

Cesarean section for which the decision was made during labor, after spontaneous or induced onset of labor. The mode of birth is determined by routine obstetric care and is not assigned by the investigators.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Birth Satisfaction Scale-Revised (BSS-R) Total Score
Periodo de tiempo: Once, between 24 and 48 hours after birth (before hospital discharge)

Birth satisfaction measured with the validated Turkish version of the Birth Satisfaction Scale-Revised (T-BSS-R), a 10-item self-report questionnaire. Each item is rated on a 5-point Likert scale and scored 0 to 4; the total score ranges from 0 to 40, with higher scores indicating greater birth satisfaction. Total scores are compared among the three mode-of-birth groups.

Once, between 24 and 48 hours after birth (before hospital discharge)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
BSS-R Quality of Care Provision Subscale Score
Periodo de tiempo: Once, between 24 and 48 hours after birth (before hospital discharge)

Four-item subscale of the T-BSS-R. Score range 0 to 16; higher scores indicate greater satisfaction with the quality of care received. Compared among the three mode-of-birth groups.

Once, between 24 and 48 hours after birth (before hospital discharge)
BSS-R Women's Personal Attributes Subscale Score
Periodo de tiempo: Once, between 24 and 48 hours after birth (before hospital discharge)

Two-item subscale of the T-BSS-R covering anxiety and sense of control during labor and birth. Score range 0 to 8; higher scores indicate a more positive experience. Compared among the three mode-of-birth groups.

Once, between 24 and 48 hours after birth (before hospital discharge)
BSS-R Stress Experienced During Labour Subscale Score
Periodo de tiempo: Once, between 24 and 48 hours after birth (before hospital discharge)

Four-item subscale of the T-BSS-R. Score range 0 to 16; higher scores indicate less stress experienced during labor and birth. Compared among the three mode-of-birth groups.

Once, between 24 and 48 hours after birth (before hospital discharge)
Postpartum Pain Intensity (Visual Analog Scale) and Its Correlation With the BSS-R Total Score
Periodo de tiempo: Once, between 24 and 48 hours after birth (before hospital discharge)

Pain intensity at the time of the survey on a 0 to 10 Visual Analog Scale (VAS; 0 = no pain, 10 = worst imaginable pain), taken from routine ward pain monitoring. The correlation (Pearson or Spearman) between the VAS score and the BSS-R total score is reported.

Once, between 24 and 48 hours after birth (before hospital discharge)
Factors Independently Associated With the BSS-R Total Score
Periodo de tiempo: Once, between 24 and 48 hours after birth (before hospital discharge)

Multiple linear regression of the BSS-R total score (0 to 40) on pre-specified variables: mode of birth (reference: spontaneous vaginal birth), age, education level, perceived income, parity, postpartum VAS score, induction of labor, epidural analgesia, presence of a birth companion, preferred mode of birth during pregnancy, history of anxiety or depression during pregnancy, 5-minute Apgar score, birth weight, and time from birth to assessment. Reported as unstandardized (B) and standardized (beta) coefficients with 95% confidence intervals.

Once, between 24 and 48 hours after birth (before hospital discharge)
Association Between Time From Birth to Assessment and the BSS-R Total Score
Periodo de tiempo: Once, between 24 and 48 hours after birth (before hospital discharge)

Time from birth to questionnaire completion, recorded in hours as a continuous variable, and its association with the BSS-R total score (correlation and the regression coefficient in the multivariable model).

Once, between 24 and 48 hours after birth (before hospital discharge)

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Proportion of Participants With the Maximum BSS-R Total Score (Ceiling Effect)
Periodo de tiempo: Once, between 24 and 48 hours after birth (before hospital discharge)

Percentage of participants scoring 40 out of 40 on the BSS-R, overall and in each mode-of-birth group, reported together with the distribution of total scores.

Once, between 24 and 48 hours after birth (before hospital discharge)

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

10 de septiembre de 2026

Finalización primaria (Estimado)

10 de diciembre de 2026

Finalización del estudio (Estimado)

10 de diciembre de 2026

Fechas de registro del estudio

Enviado por primera vez

11 de noviembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

11 de noviembre de 2026

Publicado por primera vez (Actual)

17 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

17 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

11 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

There is no plan to make individual participant data available to other researchers. Results will be shared in aggregate form through peer-reviewed publication and scientific meetings.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir